Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 69

    1.

    [No title available]

    McHutchison JG, Sulkowski MS.

    Gastroenterology. 2009 Nov 19. [Epub ahead of print] No abstract available. PMID: 19932210 [PubMed - as supplied by publisher]

    2.

    Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.

    Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS.

    AIDS. 2009 Nov 27;23(18):2397-404.PMID: 19773633 [PubMed - in process]Related articles

    3.

    Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.

    Rodriguez-Torres M, Sulkowski MS, Chung RT, Hamzeh FM, Jensen DM.

    J Viral Hepat. 2009 Aug 5. [Epub ahead of print]PMID: 19674282 [PubMed - as supplied by publisher]Related articles

    4.

    Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

    McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team.

    N Engl J Med. 2009 Aug 6;361(6):580-93. Epub 2009 Jul 22. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1027. PMID: 19625712 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.

    Chaudhry AA, Sulkowski MS, Chander G, Moore RD.

    HIV Med. 2009 Mar;10(3):133-42. Epub 2008 Dec 20.PMID: 19207596 [PubMed - in process]Related articlesFree article

    6.

    Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.

    Nelson DR, Rustgi V, Balan V, Sulkowski MS, Davis GL, Muir AJ, Lambiase LR, Dickson RC, Weisner RH, Fiscella M, Cronin PW, Pulkstenis E, McHutchison JG, Subramanian GM.

    Clin Gastroenterol Hepatol. 2009 Feb;7(2):212-8. Epub 2008 Nov 7.PMID: 19061971 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.

    Bonkovsky HL, Tice AD, Yapp RG, Bodenheimer HC Jr, Monto A, Rossi SJ, Sulkowski MS.

    Am J Gastroenterol. 2008 Nov;103(11):2757-65. Epub 2008 Aug 5.PMID: 18684176 [PubMed - indexed for MEDLINE]Related articles

    8.

    Detection of liver disease in injection drug users.

    Thomas DL, Sulkowski MS.

    J Addict Dis. 2008;27(2):19-24.PMID: 18681188 [PubMed - indexed for MEDLINE]Related articles

    9.

    Management of hepatic complications in HIV-infected persons.

    Sulkowski MS.

    J Infect Dis. 2008 May 15;197 Suppl 3:S279-93. Review.PMID: 18447614 [PubMed - indexed for MEDLINE]Related articles

    10.

    Viral hepatitis and HIV coinfection.

    Sulkowski MS.

    J Hepatol. 2008 Feb;48(2):353-67. Epub 2007 Dec 4. Review.PMID: 18155314 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.

    Hoffmann CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD.

    AIDS. 2008 Jan 2;22(1):67-74.PMID: 18090393 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

    Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL.

    AIDS. 2007 Oct 18;21(16):2209-16.PMID: 18090048 [PubMed - indexed for MEDLINE]Related articles

    13.

    The HIV-coinfected patient: managing viral hepatitis.

    Sulkowski MS.

    J Acquir Immune Defic Syndr. 2007 Jul 1;45 Suppl 2:S36-7. Review. No abstract available. PMID: 17704690 [PubMed - indexed for MEDLINE]Related articles

    14.

    Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

    Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ; North American Liver Cancer in HIV Study Group.

    J Hepatol. 2007 Oct;47(4):527-37. Epub 2007 Jul 19.PMID: 17692986 [PubMed - indexed for MEDLINE]Related articles

    15.

    Needlestick injuries among surgeons in training.

    Makary MA, Al-Attar A, Holzmueller CG, Sexton JB, Syin D, Gilson MM, Sulkowski MS, Pronovost PJ.

    N Engl J Med. 2007 Jun 28;356(26):2693-9.PMID: 17596603 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Therapeutic issues in HIV/HCV-coinfected patients.

    Sulkowski MS, Benhamou Y.

    J Viral Hepat. 2007 Jun;14(6):371-86. Review.PMID: 17501757 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Specific targeted antiviral therapy for hepatitis C.

    Sulkowski MS.

    Curr Gastroenterol Rep. 2007 Mar;9(1):5-13. Review.PMID: 17335672 [PubMed - indexed for MEDLINE]Related articles

    18.

    Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C.

    Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Garcia A, Moore PA, Yu R, Subramanian GM.

    Antivir Ther. 2006;11(7):901-8.PMID: 17302252 [PubMed - indexed for MEDLINE]Related articles

    19.

    Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.

    Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB.

    J Viral Hepat. 2007 Feb;14(2):107-15.PMID: 17244250 [PubMed - indexed for MEDLINE]Related articles

    20.

    Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

    Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS.

    AIDS. 2006 Nov 28;20(18):2361-9.PMID: 17117023 [PubMed - indexed for MEDLINE]Related articles

    21.

    Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C.

    Balan V, Aravind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G.

    Hepatol Res. 2006 Dec;36(4):277-87. Epub 2006 Oct 9.PMID: 17030011 [PubMed - in process]Related articles

    22.

    Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.

    Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS.

    J Viral Hepat. 2006 Oct;13(10):683-9.PMID: 16970600 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.

    Hornberger J, Torriani FJ, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K.

    J Clin Virol. 2006 Aug;36(4):283-91. Epub 2006 Jun 9.PMID: 16765638 [PubMed - indexed for MEDLINE]Related articles

    24.

    A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.

    Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Post AB, Redfield RR, Davis GL, Neumann AU, Osborn BL, Freimuth WW, Subramanian GM.

    Antivir Ther. 2006;11(1):35-45.PMID: 16518958 [PubMed - indexed for MEDLINE]Related articles

    25.

    Treatment algorithm for the management of hepatitis C in HIV-coinfected persons.

    Sulkowski MS.

    J Hepatol. 2006;44(1 Suppl):S49-55. Epub 2005 Nov 28. Review.PMID: 16360232 [PubMed - indexed for MEDLINE]Related articles

    26.

    Therapy insight: Management of hepatitis C in patients coinfected with HIV.

    Sulkowski MS.

    Nat Clin Pract Gastroenterol Hepatol. 2005 May;2(5):223-31. Review.PMID: 16265205 [PubMed - indexed for MEDLINE]Related articles

    27.

    Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness.

    Sulkowski MS, Thomas DL.

    AIDS. 2005 Oct;19 Suppl 3:S8-12. Review. No abstract available. PMID: 16251833 [PubMed - indexed for MEDLINE]Related articles

    28.

    A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

    Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA.

    AIDS. 2005 Oct;19 Suppl 3:S179-89. Review.PMID: 16251816 [PubMed - indexed for MEDLINE]Related articles

    29.

    Management of the hematologic complications of hepatitis C therapy.

    Sulkowski MS.

    Clin Liver Dis. 2005 Nov;9(4):601-16, vi. Review.PMID: 16207566 [PubMed - indexed for MEDLINE]Related articles

    30.

    Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black box.

    Thio CL, Sulkowski MS, Thomas DL.

    Clin Infect Dis. 2005 Oct 1;41(7):1035-40. Epub 2005 Aug 24. Review. No abstract available. Erratum in: Clin Infect Dis. 2005 Nov;41(9):1371. PMID: 16142671 [PubMed - indexed for MEDLINE]Related articles

    31.

    Hepatitis C virus infection in HIV-infected patients.

    Sulkowski MS.

    Curr HIV/AIDS Rep. 2004 Sep;1(3):128-35. Review.PMID: 16091233 [PubMed - indexed for MEDLINE]Related articles

    32.

    Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial.

    Sulkowski MS, Dieterich DT, Bini EJ, Bräu N, Alvarez D, Dejesus E, Leitz GJ; for the HIV/HCV Coinfection Study Group.

    J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):504-6. No abstract available. PMID: 16010180 [PubMed - indexed for MEDLINE]Related articles

    33.

    Liver enzyme values in injection drug users with chronic hepatitis C.

    Mehta SH, Netski D, Sulkowski MS, Strathdee SA, Vlahov D, Thomas DL.

    Dig Liver Dis. 2005 Sep;37(9):674-80.PMID: 15951255 [PubMed - indexed for MEDLINE]Related articles

    34.

    Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

    Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL.

    AIDS. 2005 Mar 24;19(6):585-92.PMID: 15802977 [PubMed - indexed for MEDLINE]Related articles

    35.

    Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.

    Sulkowski MS, Thomas DL.

    Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S263-9. Review.PMID: 15768333 [PubMed - indexed for MEDLINE]Related articles

    36.

    The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

    Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS.

    Hepatology. 2005 Jan;41(1):123-31.PMID: 15619237 [PubMed - indexed for MEDLINE]Related articles

    37.

    Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.

    Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD.

    AIDS. 2004 Nov 19;18(17):2277-84.PMID: 15577540 [PubMed - indexed for MEDLINE]Related articles

    38.

    Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.

    Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH; PROACTIVE Study Group.

    Hepatology. 2004 Dec;40(6):1450-8.PMID: 15565613 [PubMed - indexed for MEDLINE]Related articles

    39.

    Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.

    Sterling RK, Sulkowski MS.

    Semin Liver Dis. 2004;24 Suppl 2:61-8. Review.PMID: 15346248 [PubMed - indexed for MEDLINE]Related articles

    40.

    Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

    Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group.

    Gastroenterology. 2004 May;126(5):1302-11.PMID: 15131791 [PubMed - indexed for MEDLINE]Related articles

    41.

    Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

    Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R.

    J Viral Hepat. 2004 May;11(3):243-50.PMID: 15117326 [PubMed - indexed for MEDLINE]Related articles

    42.

    Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person.

    Sulkowski MS.

    Hepatology. 2004 Apr;39(4):906-8. Review. No abstract available. PMID: 15057892 [PubMed - indexed for MEDLINE]Related articles

    43.

    Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.

    Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT; Hepatitis Resource Network Clinical Trials Group.

    J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):464-72.PMID: 15021311 [PubMed - indexed for MEDLINE]Related articles

    44.

    Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors.

    Sulkowski MS.

    Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S90-7.PMID: 14986280 [PubMed - indexed for MEDLINE]Related articles

    45.

    Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.

    Dieterich DT, Wasserman R, Bräu N, Hassanein TI, Bini EJ, Bowers PJ, Sulkowski MS.

    Am J Gastroenterol. 2003 Nov;98(11):2491-9.PMID: 14638354 [PubMed - indexed for MEDLINE]Related articles

    46.

    Anemia in the treatment of hepatitis C virus infection.

    Sulkowski MS.

    Clin Infect Dis. 2003;37 Suppl 4:S315-22.PMID: 14582000 [PubMed - indexed for MEDLINE]Related articles

    47.

    The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.

    Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS.

    J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):577-84.PMID: 12902801 [PubMed - indexed for MEDLINE]Related articles

    48.

    Antiretroviral-associated liver injury.

    Ogedegbe AO, Sulkowski MS.

    Clin Liver Dis. 2003 May;7(2):475-99. Review.PMID: 12879995 [PubMed - indexed for MEDLINE]Related articles

    49.

    Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors.

    Sulkowski MS.

    Semin Liver Dis. 2003 May;23(2):183-94. Review.PMID: 12800071 [PubMed - indexed for MEDLINE]Related articles

    50.

    Hepatitis C in the HIV-infected patient.

    Sulkowski MS, Thomas DL.

    Clin Liver Dis. 2003 Feb;7(1):179-94. Review.PMID: 12691466 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...